-
1
-
-
0025978216
-
Phase I clinical, plasma, and cellular pharmacology study of gemcitabine
-
Abbruzzese, J. L., R. Grunewald, E. A. Weeks, D. Gravel, T. Adams, B. Nowak, S. Mineishi, P. Tarassoff, W. Satterlee, and M. N. Raber. 1991. Phase I clinical, plasma, and cellular pharmacology study of gemcitabine. J. Clin. Oncol. 9:491-498.
-
(1991)
J. Clin. Oncol.
, vol.9
, pp. 491-498
-
-
Abbruzzese, J.L.1
Grunewald, R.2
Weeks, E.A.3
Gravel, D.4
Adams, T.5
Nowak, B.6
Mineishi, S.7
Tarassoff, P.8
Satterlee, W.9
Raber, M.N.10
-
2
-
-
0022887623
-
Absence of genotoxic effects in cells exposed to four ketonucleoside derivatives
-
Alaoui-Jamali, M. A., C. Lasne, K. Antonakis, and I. Chouroulinkov. 1986. Absence of genotoxic effects in cells exposed to four ketonucleoside derivatives. Mutagenesis 1:411-417.
-
(1986)
Mutagenesis
, vol.1
, pp. 411-417
-
-
Alaoui-Jamali, M.A.1
Lasne, C.2
Antonakis, K.3
Chouroulinkov, I.4
-
3
-
-
0023266663
-
Relationship between the structure and cytotoxic activity of new unsaturated ketonucleosides tested on eight cell lines
-
Alaoui-Jamali, M. A., M. J. Arvor-Ergon, M. Bessodes, K. Antonakis, and I. Chouroulinkov. 1987. Relationship between the structure and cytotoxic activity of new unsaturated ketonucleosides tested on eight cell lines. Eur. J. Med. Chem. 22:305-310.
-
(1987)
Eur. J. Med. Chem.
, vol.22
, pp. 305-310
-
-
Alaoui-Jamali, M.A.1
Arvor-Ergon, M.J.2
Bessodes, M.3
Antonakis, K.4
Chouroulinkov, I.5
-
4
-
-
0023640706
-
Structure activity relationship of ketonucleosides
-
Alaoui-Jamali, M. A., H. Tapiero, K. Antonakis, and I. Chouroulinkov. 1987. Structure activity relationship of ketonucleosides. Anticancer Res. 7:501-504.
-
(1987)
Anticancer Res.
, vol.7
, pp. 501-504
-
-
Alaoui-Jamali, M.A.1
Tapiero, H.2
Antonakis, K.3
Chouroulinkov, I.4
-
5
-
-
0031298124
-
The role of erbB2 tyrosine kinase receptor in cellular intrinsic chemoresistance: Mechanisms and implications
-
Alaoui-Jamali, M. A., J. Paterson, A. E. Al-Mostapha, and L. Yen. 1997. The role of erbB2 tyrosine kinase receptor in cellular intrinsic chemoresistance: mechanisms and implications. Biochem. Cell Biol. 75:315-325.
-
(1997)
Biochem. Cell Biol.
, vol.75
, pp. 315-325
-
-
Alaoui-Jamali, M.A.1
Paterson, J.2
Al-Mostapha, A.E.3
Yen, L.4
-
6
-
-
0003405331
-
-
American Type Culture Collection, Rockville, Md.
-
5a. American Type Culture Collection. 1992. Catalogue of cell lines & hybridomas, 7th ed. American Type Culture Collection, Rockville, Md.
-
(1992)
Catalogue of Cell Lines & Hybridomas, 7th Ed.
-
-
-
7
-
-
0016612143
-
Synthesis of nucleoside analogs
-
Antonakis, K. 1975. Synthesis of nucleoside analogs. Chimia 29:59.
-
(1975)
Chimia
, vol.29
, pp. 59
-
-
Antonakis, K.1
-
8
-
-
0011620355
-
Synthesis of ketonucleosides with biological activity
-
Antonakis, K. 1984. Synthesis of ketonucleosides with biological activity. Carbohydr. Chem. Biochem. 42:227.
-
(1984)
Carbohydr. Chem. Biochem.
, vol.42
, pp. 227
-
-
Antonakis, K.1
-
9
-
-
0029670589
-
p53 in signaling checkpoint arrest or apoptosis
-
Bates, S., and K. H. Vousden. 1996. p53 in signaling checkpoint arrest or apoptosis. Curr. Opin. Genet. Dev. 6:12-18.
-
(1996)
Curr. Opin. Genet. Dev.
, vol.6
, pp. 12-18
-
-
Bates, S.1
Vousden, K.H.2
-
10
-
-
0028290891
-
The neu-oncogene: Signal transduction pathways, transformation mechanisms and evolving therapies
-
Dougall, C. W., X. Qian, C. N. Peterson, J. M. Miller, A. Samanta, and I. M. Greene. 1994. The neu-oncogene: signal transduction pathways, transformation mechanisms and evolving therapies. Oncogene 9:2109-2123.
-
(1994)
Oncogene
, vol.9
, pp. 2109-2123
-
-
Dougall, C.W.1
Qian, X.2
Peterson, C.N.3
Miller, J.M.4
Samanta, A.5
Greene, I.M.6
-
11
-
-
0022102126
-
Down modulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodies
-
Drebin, A. J., C. V. Link, F. D. Stern, A. R. Weinberg, and I. M. Greene. 1985. Down modulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodies. Cell 41:695-706.
-
(1985)
Cell
, vol.41
, pp. 695-706
-
-
Drebin, A.J.1
Link, C.V.2
Stern, F.D.3
Weinberg, A.R.4
Greene, I.M.5
-
12
-
-
0028171454
-
p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents
-
Fan, S., W. S. el-Deiry, I. Bae, J. Freeman, D. Jondle, K. Bhatia, A. J. Fornace, Jr., I. Magrath, K. W. Kohn, and P. M. O'Connor. 1994. p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents. Cancer Res. 54:5824-5830.
-
(1994)
Cancer Res.
, vol.54
, pp. 5824-5830
-
-
Fan, S.1
El-Deiry, W.S.2
Bae, I.3
Freeman, J.4
Jondle, D.5
Bhatia, K.6
Fornace A.J., Jr.7
Magrath, I.8
Kohn, K.W.9
O'Connor, P.M.10
-
13
-
-
0030007671
-
Recent advances in the treatment of non-small cell lung cancer
-
Goss, G. D., S. Dahrouge, and C. A. Lochrin. 1996. Recent advances in the treatment of non-small cell lung cancer. Anti-Cancer drugs 7:3633-3685.
-
(1996)
Anti-Cancer Drugs
, vol.7
, pp. 3633-3685
-
-
Goss, G.D.1
Dahrouge, S.2
Lochrin, C.A.3
-
14
-
-
0020602958
-
Interactions of cytostatic unsaturated ketonucleosides with sulfhydryl containing cell constituents
-
Halmos, T., A. Cardon, and K. Antonakis. 1983. Interactions of cytostatic unsaturated ketonucleosides with sulfhydryl containing cell constituents. Chem. Biol. Interact. 46:11-29.
-
(1983)
Chem. Biol. Interact.
, vol.46
, pp. 11-29
-
-
Halmos, T.1
Cardon, A.2
Antonakis, K.3
-
15
-
-
0345139070
-
Nucleophilic additions on a β-unsaturated ketonucleoside. Preparation of amino- and thio-kelonucleosides derived from 2′,3′,6′-trideoxy sugars
-
Herscovici, J., J. M. Argoullon, M. J. Egron, and K. Antonakis. 1983. Nucleophilic additions on a β-unsaturated ketonucleoside. Preparation of amino- and thio-kelonucleosides derived from 2′,3′,6′-trideoxy sugars. Carbohydr. Res. 112:301-306.
-
(1983)
Carbohydr. Res.
, vol.112
, pp. 301-306
-
-
Herscovici, J.1
Argoullon, J.M.2
Egron, M.J.3
Antonakis, K.4
-
17
-
-
0026040393
-
Keto-C-glycosides. a new class of antitumor compounds
-
Herscovici, J., I. Bennani-Baiti, C. Frayssinet, and K. Antonakis. 1991. Keto-C-glycosides. A new class of antitumor compounds. Biomed. Chem. Lett. 1:395-398.
-
(1991)
Biomed. Chem. Lett.
, vol.1
, pp. 395-398
-
-
Herscovici, J.1
Bennani-Baiti, I.2
Frayssinet, C.3
Antonakis, K.4
-
18
-
-
0026337563
-
Design, synthesis and cytotoxic evaluation of keto-C-glycoside fatty acid conjugates
-
Herscovici, J., I. Bennani-Baiti, R. Montserret, C. Frayssinet, and K. Antonakis. 1991. Design, synthesis and cytotoxic evaluation of keto-C-glycoside fatty acid conjugates. Biomed. Chem. Lett. 1:721-724.
-
(1991)
Biomed. Chem. Lett.
, vol.1
, pp. 721-724
-
-
Herscovici, J.1
Bennani-Baiti, I.2
Montserret, R.3
Frayssinet, C.4
Antonakis, K.5
-
19
-
-
0028297469
-
Unsaturated epoxy-C-glycosides. A new class of antitumor compounds with DNA cleavage properties
-
Herscovici, J., C. Uriel, J. Uriel, and K. Antonakis. 1994. Unsaturated epoxy-C-glycosides. A new class of antitumor compounds with DNA cleavage properties. Biomed. Chem. Lett. 4:421-426.
-
(1994)
Biomed. Chem. Lett.
, vol.4
, pp. 421-426
-
-
Herscovici, J.1
Uriel, C.2
Uriel, J.3
Antonakis, K.4
-
21
-
-
0027518618
-
Proto-oncogene and growth factor/receptor expression in the establishment of primary human non-small cell lung carcinoma cell lines
-
Liu, C., and M.-S. Tsao. 1993. Proto-oncogene and growth factor/receptor expression in the establishment of primary human non-small cell lung carcinoma cell lines. Am. J. Pathol. 142:413-423.
-
(1993)
Am. J. Pathol.
, vol.142
, pp. 413-423
-
-
Liu, C.1
Tsao, M.-S.2
-
22
-
-
0027174951
-
p53 alterations in non-small cell lung cancers correlate with metastatic involvement of hilar and mediastinal lymph nodes
-
Marchetti, A., F. Buttitta, G. Merlo, F. Diella, S. Pellegrini, S. Pepe, P. Macchiarini, A. Chella, C. A. Angeletti, R. Callahan, et al. 1993. p53 alterations in non-small cell lung cancers correlate with metastatic involvement of hilar and mediastinal lymph nodes. Cancer Res. 53:2846.
-
(1993)
Cancer Res.
, vol.53
, pp. 2846
-
-
Marchetti, A.1
Buttitta, F.2
Merlo, G.3
Diella, F.4
Pellegrini, S.5
Pepe, S.6
Macchiarini, P.7
Chella, A.8
Angeletti, C.A.9
Callahan, R.10
-
23
-
-
0028233833
-
Depletion of the erbB-2 gene product p185 by benzoquinoid ansamycins
-
Miller, P., C. DiOrio, M. Moyer, C. R. Schnur, A. Bruskin, W. Cullen, and D. J. Moyer. 1994. Depletion of the erbB-2 gene product p185 by benzoquinoid ansamycins. Cancer Res. 54:2724-2730.
-
(1994)
Cancer Res.
, vol.54
, pp. 2724-2730
-
-
Miller, P.1
DiOrio, C.2
Moyer, M.3
Schnur, C.R.4
Bruskin, A.5
Cullen, W.6
Moyer, D.J.7
-
24
-
-
0027137816
-
Mutations of the p53 gene as a predictor of poor prognosis in patients with non-small cell lung cancer
-
Mitsudomi, T., T. Oyama, T. Kusano, T. Osaki, R. Nakanishi, and T. Shirakusa. 1993. Mutations of the p53 gene as a predictor of poor prognosis in patients with non-small cell lung cancer. J. Natl. Cancer Inst. 84:2018-2023.
-
(1993)
J. Natl. Cancer Inst.
, vol.84
, pp. 2018-2023
-
-
Mitsudomi, T.1
Oyama, T.2
Kusano, T.3
Osaki, T.4
Nakanishi, R.5
Shirakusa, T.6
-
25
-
-
0026543204
-
p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features
-
Mitsudomi, T., S. M. Steinberg, M. M. Nau, D. Carbone, D. D'Amico, S. Bodner, H. K. Oie, R. I. Linnoila, J. L. Mulshine, J. D. Minna, et al. 1992. p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features. Oncogene 7:171-180.
-
(1992)
Oncogene
, vol.7
, pp. 171-180
-
-
Mitsudomi, T.1
Steinberg, S.M.2
Nau, M.M.3
Carbone, D.4
D'Amico, D.5
Bodner, S.6
Oie, H.K.7
Linnoila, R.I.8
Mulshine, J.L.9
Minna, J.D.10
-
26
-
-
0028273743
-
Integrated clinical and basic studies related to circumventing non-small cell lung cancer drug resistance
-
Mulshine, J. L., B. E. Johnson, A. F. Gazdar, G. L. Shaw, B. S. Kramer, T. Mitsudomi, J. D. Minna, H. Pass, R. Phelps, B. Ghosh, et al. 1994. Integrated clinical and basic studies related to circumventing non-small cell lung cancer drug resistance. Lung Cancer 10(Suppl. 1):S73-S81.
-
(1994)
Lung Cancer
, vol.10
, Issue.1 SUPPL.
-
-
Mulshine, J.L.1
Johnson, B.E.2
Gazdar, A.F.3
Shaw, G.L.4
Kramer, B.S.5
Mitsudomi, T.6
Minna, J.D.7
Pass, H.8
Phelps, R.9
Ghosh, B.10
-
27
-
-
0026549424
-
Overexpression of the c-erbB2/neu-encoded p185 protein in primary lung cancer
-
Shi, D., G. He, S. Cao, W. Pan, H.-Z. Zhang, D. Yu, and M.-C. Hung. 1992. Overexpression of the c-erbB2/neu-encoded p185 protein in primary lung cancer. Mol. Carcinog. 5:213-218.
-
(1992)
Mol. Carcinog.
, vol.5
, pp. 213-218
-
-
Shi, D.1
He, G.2
Cao, S.3
Pan, W.4
Zhang, H.-Z.5
Yu, D.6
Hung, M.-C.7
-
28
-
-
0024337144
-
Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer
-
Slamon, D. J., W. Godolphin, L. A. Jones, S. G. Wong, D. E. Keith, W. J. Levin, S. G. Stuart, J. Udove, A. Ulrich, and M. F. Press. 1989. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244:707-712.
-
(1989)
Science
, vol.244
, pp. 707-712
-
-
Slamon, D.J.1
Godolphin, W.2
Jones, L.A.3
Wong, S.G.4
Keith, D.E.5
Levin, W.J.6
Stuart, S.G.7
Udove, J.8
Ulrich, A.9
Press, M.F.10
-
29
-
-
0027215146
-
Correlation of intrinsic chemoresistance of non-small-cell lung cancer cell lines with HER-2/neu gene expression but not with ras gene mutations
-
Tsai, C.-M., K.-T. Chang, R.-P. Perng, T. Mitsudomi, M.-H. Chen, C. Kadoyama, and A. F. Gazdar. 1993. Correlation of intrinsic chemoresistance of non-small-cell lung cancer cell lines with HER-2/neu gene expression but not with ras gene mutations. J. Natl. Cancer Inst. 85:897-901.
-
(1993)
J. Natl. Cancer Inst.
, vol.85
, pp. 897-901
-
-
Tsai, C.-M.1
Chang, K.-T.2
Perng, R.-P.3
Mitsudomi, T.4
Chen, M.-H.5
Kadoyama, C.6
Gazdar, A.F.7
-
31
-
-
0030019658
-
Cytotoxic effects of gemcitabine-containing regimens against human non-small cell lung cancer cell lines which express different levels of p185neu
-
Tsai, C.-M., K.-T. Chang, J.-Y. Chen, Y.-M. Chen, M.-H. Chen, and R.-P. Perng. 1996. Cytotoxic effects of gemcitabine-containing regimens against human non-small cell lung cancer cell lines which express different levels of p185neu. Cancer Res. 56:794-801.
-
(1996)
Cancer Res.
, vol.56
, pp. 794-801
-
-
Tsai, C.-M.1
Chang, K.-T.2
Chen, J.-Y.3
Chen, Y.-M.4
Chen, M.-H.5
Perng, R.-P.6
|